WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-0.28 Cr | ₹-0.57 Cr | ₹-2.03 Cr | ₹-2.04 Cr | ₹0.68 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WINDLAS BIOTECH ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-0.28 Cr |
| Mar2024 | ₹-0.57 Cr |
| Mar2023 | ₹-2.03 Cr |
| Mar2022 | ₹-2.04 Cr |
| Mar2021 | ₹0.68 Cr |
How is Deferred Tax Assets / Liabilities of WINDLAS BIOTECH Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.28 Cr | Negative | |
| Mar2024 | ₹-0.57 Cr | Negative | |
| Mar2023 | ₹-2.03 Cr | Negative | |
| Mar2022 | ₹-2.04 Cr | Negative | |
| Mar2021 | ₹0.68 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,682.9 Cr | 3.1% | -4.6% | -17.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,677.0 Cr | -2.1% | 13.6% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,458.0 Cr | -2% | 6.2% | 3.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹153,685.0 Cr | 0.5% | 8.2% | 39% | Stock Analytics | |
| CIPLA | ₹114,562.0 Cr | 1.3% | 9.5% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,095.0 Cr | 0.6% | 1% | 8.8% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 3.1% |
-4.6% |
-17.8% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses